Efficacy and safety of concomitant immunotherapy and denosumab in patients with advanced non-small cell lung cancer carrying bone metastases: A retrospective chart review

BACKGROUND: Synergistic anti-tumor effects were observed in vivo and in vitro when immune checkpoint inhibitors (ICIs) were combined with denosumab. However, the clinical benefit and safety of this synergy have not been adequately evaluated in non-small cell lung cancer (NSCLC). METHODS: Consecutive...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Hong-Shuai, Lei, Si-Yu, Li, Jun-Ling, Xing, Pu-Yuan, Hao, Xue-Zhi, Xu, Fei, Xu, Hai-Yan, Wang, Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9464943/
https://www.ncbi.nlm.nih.gov/pubmed/36105807
http://dx.doi.org/10.3389/fimmu.2022.908436

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9464943/
https://www.ncbi.nlm.nih.gov/pubmed/36105807
http://dx.doi.org/10.3389/fimmu.2022.908436

Ejemplares similares